Monitor whether the stock can stabilize above $0.60 post-offering and whether the company can regain Nasdaq compliance by October 12, 2026. The pre-funded warrant structure suggests the offering was structured to accommodate large investors while limiting immediate voting dilution, but the potential for full exercise adds significant overhang.
Price Chart
Executive Summary
Arbe Robotics is conducting a dilutive underwritten public offering of 833,334 ordinary shares and pre-funded warrants for 24,166,666 ordinary shares at $0.60 per share, raising approximately $13.8 million in net proceeds for working capital and general corporate purposes. The offering represents a 19% dilution to existing shareholders based on shares outstanding pre-offering, and the stock is trading below the Nasdaq minimum bid price requirement with a compliance deadline of October 12, 2026.
Key Facts
- Offering of 833,334 ordinary shares and pre-funded warrants for 24,166,666 ordinary shares at $0.60 per share
- Total gross proceeds of approximately $15.0 million; net proceeds estimated at $13.8 million
- Offering price of $0.60 represents a 5.5% discount to the September 25, 2026 closing price of $0.6350
- Pro forma shares outstanding of 128,139,176 (excluding pre-funded warrant exercise) — a 0.7% increase from 127,305,842
- If all pre-funded warrants are exercised, total shares outstanding would increase to 152,305,842 — a 19.6% dilution
- Net tangible book value per share increases from $0.32 to $0.36, but new investors face immediate dilution of $0.24 per share
- Company received a Nasdaq deficiency notice on April 13, 2026 for failing to meet the $1.00 minimum bid price; compliance deadline is October 12, 2026
- Underwriter is Canaccord Genuity with a 90-day lock-up on additional share issuance
Financial Impact
Dilutive offering raising $13.8 million net proceeds; potential 19.6% dilution if all pre-funded warrants exercised
Risk Factors
- Nasdaq delisting risk if minimum bid price compliance not regained by October 12, 2026
- Significant dilution from potential exercise of 24.2 million pre-funded warrants
- Stock trading at $0.6350 — only 5.5% above offering price, leaving little buffer against further declines
- Company has accumulated deficit of $317.9 million and negative working capital dynamics
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-103771 |
| Document: 0001213900-26-103771-index-headers.html | 0001213900-26-103771 |
| Document: 0001213900-26-103771-index.html | 0001213900-26-103771 |
| Document: 0001213900-26-103771.txt | 0001213900-26-103771 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 6-K | $0.5000 $0.4671 | ▼ −6.58% | ▼ −7.03% | $0.4580 (−8.40%) |
Oct 6, 2026 21d ago | 25-NSE | $0.5921 $0.5000 | ▲ +15.55% | ▲ +14.57% | $0.4580 (+22.65%) |
Sep 28, 2026 29d ago | Press Release | $0.6076 $0.5976 | ▲ +1.65% | ▲ +3.59% | $0.4580 (+24.62%) |
Sep 28, 2026 29d ago | 6-K | $0.6000 $0.5910 | ▲ +1.50% | ▲ +2.70% | $0.4580 (+23.67%) |
Sep 28, 2026 29d ago | 424B5 | $0.6000 $0.5910 | ▲ +1.50% | ▲ +2.70% | $0.4580 (+23.67%) |
Sep 25, 2026 4w ago | 6-K | $0.6350 $0.6126 | ▲ +3.53% | ▲ +3.31% | $0.4580 (+27.87%) |
Sep 10, 2026 6w ago | 6-K | $0.7836 $0.6700 | ▼ −14.50% | ▼ −14.28% | $0.4580 (−41.55%) |
Sep 8, 2026 7w ago | 6-K | $0.7431 $0.6917 | ▼ −6.92% | ▼ −5.80% | $0.4580 (−38.37%) |
Sep 4, 2026 7w ago | 6-K | $0.7431 $0.6917 | ▼ −6.92% | ▼ −5.80% | $0.4580 (−38.37%) |
Aug 12, 2026 10w ago | 6-K | $0.7680 $0.7491 | ▲ +2.46% | ▲ +0.50% | $0.4580 (+40.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers